Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...

Implantica AG (FRA:8IM1) reports a 25% sales increase and a robust patent portfolio, while navigating operational losses and regulatory hurdles.

Weight loss drugs like Ozempic and Wegovy, originally for diabetes, are now in high demand as they enable significant fat ...

Trump’s wide-ranging executive order also focuses on slashing healthcare costs. It comes a day after the administration ...

Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts by Novo Nordisk to ramp up its production capacity for semaglutide. The Danish drugmaker has asked the FDA to move ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Health retailer The Vitamin Shoppe has seen a spike in demand for supplements that could help with loss of appetite, ...

In a significant step toward strengthening healthcare infrastructure in the Turks and Caicos Islands (TCI), the Ministry of ...

At its second attempt, Astellas has won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for certain gastric cancers. The US regulator approved Vyloy ...